🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the oral bioavailability of two ne...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02396147
Treatments Being Tested
Eating disorders (EDs) have the highest rate of mortality of any mental ill...
Status
Completed
Location
University of Michigan
Start Date
2015-01
Trial ID
NCT02284685
Treatments Being Tested
The purpose of this study is to assess the bioequivalence between HR20031 F...
Status
Completed
Location
Jinan Central Hospital
Start Date
2023-01-31
Trial ID
NCT05682495
A study to evaluate the drug effect, safety, and tolerability of BMS-986259...
Status
Completed
Location
Clinical Pharmacology of Miami
Start Date
2020-02-26
Trial ID
NCT04237831
Treatments Being Tested
This study will evaluate the safety, tolerability, and efficacy of engineer...
Status
Recruiting
Location
City of Hope
Start Date
2019-04-08
Trial ID
NCT03802695
Treatments Being Tested
This is a Phase I open-label, multicenter study designed to evaluate the sa...
Status
Terminated
Location
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center
Start Date
2019-07-22
Trial ID
NCT04045028
Treatments Being Tested
The purpose of Study BCB111 is to collect efficacy, pharmacokinetic, pharma...
Status
Completed
Location
Research Site
Start Date
2010-05
Trial ID
NCT01104701
The objective of this proposal is to evaluate the effectiveness of rehabili...
Status
Unknown
Location
Naval Medical Center San Diego
Start Date
2016-05
Trial ID
NCT02719964
An open-label randomized multicenter clinical study comparing three regimes...
Status
Completed
Location
Hopital Pellegrin Tripode
Start Date
2005-05
Trial ID
NCT00538265
Treatments Being Tested
SB497115 is an oral agent which activates the thrombopoietin receptor and i...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04
Trial ID
NCT00110799